A Study of Aβ Oligomers in the Temporal Cortex and Cerebellum of Patients with Neuropathologically Confirmed Alzheimer's Disease Compared to Aged Controls

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neurodegenerative Diseases

• Publication date

  2016-07-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1159/000446283PMID 27400224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions.

  2016cited by this paper
• Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models*

  2015cited by this paper
• Characterization of a Novel Mouse Model of Alzheimer’s Disease—Amyloid Pathology and Unique β-Amyloid Oligomer Profile

  2015cited by this paper
• The preclinical phase of the pathological process underlying sporadic Alzheimer's disease.

  2015cited by this paper
• Moving Away from Amyloid Beta to Move on in Alzheimer Research

  2015cited by this paper
• Alzheimer disease therapy—moving from amyloid-β to tau

  2013cited by this paper
• Alzheimer disease: Aβ-independent processes—rethinking preclinical AD

  2013cited by this paper
• Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples

  2013cited by this paper
• The case for soluble Aβ oligomers as a drug target in Alzheimer's disease.

  2013cited by this paper
• Brain amyloid-β oligomers in ageing and Alzheimer's disease.

  2013cited by this paper
• β-Amyloid oligomers in aging and Alzheimer’s disease

  2013cited by this paper
• Amyloid‐beta oligomerization in Alzheimer dementia versus high‐pathology controls

  2013cited by this paper
• Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity.

  2012cited by this paper
• Soluble Aβ oligomer production and toxicity

  2012cited by this paper
• Neurotoxicity of amyloid β-protein: synaptic and network dysfunction.

  2012cited by this paper
• Synapse-binding subpopulations of Aβ oligomers sensitive to peptide assembly blockers and scFv antibodies.

  2012cited by this paper
• The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

  2012cited by this paper
• Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis

  2012cited by this paper
• Cognitive effects of cell-derived and synthetically derived Aβ oligomers.

  2011cited by this paper
• Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

  2011cited by this paper
• Linking Amyloid-β and Tau: Amyloid-β Induced Synaptic Dysfunction via Local Wreckage of the Neuronal Cytoskeleton

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Mechanisms of AD neurodegeneration may be independent of Aβ and its derivatives.

  2011cited by this paper
• Probing the biology of Alzheimer's disease in mice.

  2010cited by this paper
• Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

  2010cited by this paper
• Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines

  2010cited by this paper
• Reassessing the amyloid cascade hypothesis of Alzheimer's disease.

  2009cited by this paper
• Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic Aβ Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic Mice

  2009cited by this paper
• The presenilin-1 familial Alzheimer's disease mutation P117L decreases neuronal differentiation of embryonic murine neural progenitor cells.

  2009cited by this paper
• Novel Neuromodulation Approaches for Alzheimer’s Disease and Other Neurodegenerative Conditions

  2009cited by this paper
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008cited by this paper
• Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers

  2008cited by this paper
• Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.

  2008cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• Monoclonal antibodies that target pathological assemblies of Aβ

  2007cited by this paper
• Clinicopathologic correlates in the oldest-old: Commentary on "No disease in the brain of a 115-year-old woman".

  2007cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience

  2006cited by this paper
• Soluble Aβ oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain

  2005cited by this paper
• Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain.

  2005cited by this paper
• Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology.

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers

  2004cited by this paper
• Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

  2004cited by this paper
• Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease

  2003cited by this paper
• Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss

  2003cited by this paper
• Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease.

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain.

  2001cited by this paper
• Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?

  2001cited by this paper
• Sequence of Abeta-protein deposition in the human medial temporal lobe.

  2000cited by this paper
• Sequence of Aβ‐Protein Deposition in the Human Medial Temporal Lobe

  2000cited by this paper
• Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease

  1999cited by this paper
• Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

  1999cited by this paper
• Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

  1999cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205.

  1995cited by this paper

• Structures of Oligomeric States of Tau Protein, Amyloid-β, α-Synuclein and Prion Protein Implicated in Alzheimer’s Disease, Parkinson’s Disease and Prionopathies

  2024cites this paper
• Sensory processing deficits and related cortical pathological changes in Alzheimer’s disease

  2023cites this paper
• Oligomeropathies, inflammation and prion protein binding

  2022cites this paper
• Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

  2019cites this paper
• ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer’s disease

  2019cites this paper
• Challenges in understanding the structure/activity relationship of Aβ oligomers

  2019cites this paper
• A Comprehensive Analysis of the CaMK2A Gene and Susceptibility to Alzheimer’s Disease in the Han Chinese Population

  2019cites this paper
• Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex

  2018cites this paper
• The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade

  2018cites this paper
• A human scFv antibody that targets and neutralizes high molecular weight pathogenic amyloid‐β oligomers

  2017cites this paper
• β-amyloid expression in age-related cataract lens epithelia and the effect of β-amyloid on oxidative damage in human lens epithelial cells

  2017cites this paper
• The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation

  2017cites this paper
• Expression of MEGF10 in cholinergic and glutamatergic neurons.

  2017cites this paper